Warning: This security is no longer trading.
defunct
Aevi Genomic Medicine, Inc. (GNMX): Price and Financial Metrics
GNMX Price/Volume Stats
| Current price | $0.17 | 52-week high | $0.35 |
| Prev. close | $0.19 | 52-week low | $0.11 |
| Day low | $0.15 | Volume | 2,945,800 |
| Day high | $0.18 | Avg. volume | 3,164,141 |
| 50-day MA | $0.16 | Dividend yield | N/A |
| 200-day MA | $0.17 | Market Cap | 13.21M |
GNMX Stock Price Chart Interactive Chart >
Aevi Genomic Medicine, Inc. (GNMX) Company Bio
Aevi Genomic Medicine engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. It develops transduced autologous restorative gene therapy, TARGT platform to provide protein and peptide therapies to treat a range of chronic diseases and conditions. The company was founded in 2000 and is based in Wayne, Pennsylvania.
GNMX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 44.19% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -79.14% |
Loading social stream, please wait...